A 12-year-old boy is the first commercial patient in the world to receive an FDA-approved gene therapy for sickle cell disease, The New York Times reported May 6.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
12-year-old is 1st to receive newly approved sickle cell therapy
